Voyager Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Voyager Therapeutics has a total shareholder equity of $330.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $426.0M and $95.7M respectively. Voyager Therapeutics's EBIT is $9.1M making its interest coverage ratio -0.5. It has cash and short-term investments of $345.4M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -0.5x |
| Cash | US$345.36m |
| Equity | US$330.31m |
| Total liabilities | US$95.73m |
| Total assets | US$426.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VT6's short term assets ($373.4M) exceed its short term liabilities ($44.2M).
Long Term Liabilities: VT6's short term assets ($373.4M) exceed its long term liabilities ($51.5M).
Debt to Equity History and Analysis
Debt Level: VT6 is debt free.
Reducing Debt: VT6 had no debt 5 years ago.
Debt Coverage: VT6 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VT6 has no debt, therefore coverage of interest payments is not a concern.